# US 2024/0189362 A1 · Immunocompatible amniotic membrane products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189362 A1
- Document ID: US20240189362A1
- Status: Published application
- Kind: A1
- Application number: 18/584,350
- Filed: 2024-02-22
- Published: 2024-06-13
- Earliest claimed: 2010-02-18
- Assignees: Osiris Therapeutics, Inc.
- Applicants: Osiris Therapeutics, Inc.
- Inventors: Samson TOM; Alla DANILKOVITCH; Dana YOO; Timothy JANSEN; Jin-Qiang KUANG; Jennifer Michelle MARCONI
- Web page: https://patentgrep.com/patent/US20240189362A1

## CPC

- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A61K 35/50: Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A61K 38/1825: {Fibroblast growth factor [FGF]}
- A61K 38/1841: {Transforming growth factor [TGF]}
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61K 38/57: from animals; from humans {(A61K38/553, A61K38/556 take precedence)}
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 5/0605: {Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly}
- C12N 2500/02: Atmosphere, e.g. low oxygen conditions
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2502/025: extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

## Claims

### Claim 1

A method of treating a wound, the method comprising applying to the wound a placental product comprising an amniotic membrane, a spongy layer, and a chorionic membrane to at least a portion of the wound, wherein the spongy layer is positioned between the amniotic membrane and the chorionic membrane, and wherein the placental product:
is selectively depleted of immunogenicity;
is dried, sterile, and free of viable cells; and
releases collagen, laminin, and fibronectin after being applied to the wound.

### Claim 2 (depends on 1)

The method of claim 1, wherein the placental product does not include umbilical cord.

### Claim 3 (depends on 1)

The method of claim 1, wherein the amniotic membrane comprises extracellular matrix native to the amniotic membrane.

### Claim 4 (depends on 1)

The method of claim 1, wherein the chorionic membrane comprises extracellular matrix native to the chorionic membrane.

### Claim 5 (depends on 1)

The method of claim 1, wherein the amniotic membrane and the chorionic membrane are protease-treated.

### Claim 6 (depends on 1)

The method of claim 1, wherein the amniotic membrane and the chorionic membrane are disinfected.

### Claim 7 (depends on 1)

The method of claim 1, wherein the placental product does not include residual blood.

### Claim 8 (depends on 1)

The method of claim 1, wherein the placental product is less than 10 centimeters (cm)×10 cm in size.

### Claim 9 (depends on 1)

The method of claim 1, wherein the placental product is 1 centimeter (cm)×1 cm to 5 cm×5 cm in size.

### Claim 10 (depends on 1)

The method of claim 1, wherein the placental product is 1 centimeter (cm)×1 cm, 2 cm×2 cm, 4 cm×4 cm, 4 cm×6 cm, or 5 cm×5 cm in size.

### Claim 11 (depends on 1)

The method of claim 1, wherein the placental product is 0.02 millimeter (mm) to 0.5 mm thick.

### Claim 12 (depends on 1)

The method of claim 1, wherein the placental product is a single-use wound dressing.

### Claim 13 (depends on 1)

The method of claim 1, wherein the wound is a chronic wound, an acute wound, an ulcer, a burn, a surgical wound, or a trauma wound.

### Claim 14 (depends on 13)

The method of claim 13, wherein the ulcer is a pressure ulcer, a diabetic ulcer, or a venous ulcer.

### Claim 15 (depends on 13)

The method of claim 13, wherein the burn is a first-degree burn, second-degree burn, a partial thickness burn, a thermal burn, or a chemical burn.

### Claim 16 (depends on 13)

The method of claim 13, wherein the burn is not a full thickness or third-degree burn.

### Claim 17 (depends on 13)

The method of claim 13, wherein the surgical wound is an internal wound or an external wound gained by a surgical procedure.

### Claim 18 (depends on 13)

The method of claim 13, wherein the trauma wound is a laceration, scrape, incision, or puncture.
